Jiao hong, a member of the standing committee of the Chinese people's political consultative conference (CPPCC), suggested speeding up the construction of an emergency management system for medicines and medical devices
Post date: 2020-05-29
Drugs and medical devices, as special commodities for curing diseases and saving people, have played an important role in the prevention and control of covid-19. "strengthening the support of emergency supplies" has been included in this year's government work report.
On the 13th session of the CPPCC meeting three times, the Chinese people's political consultative conference, vice-chairman of the standing committee and vice chairman of the central committee, the state pharmaceutical administration bureau telephoto red advice, COVID - 19 epidemic prevention and control as an opportunity to further strengthen the construction of emergency medicine medical instrument management system, improve the mechanism of the major epidemic prevention and control system, deal with major public health emergencies and improve the ability and level.
"Major strategic achievements have been made in the prevention and control of the epidemic, and positive results have been achieved in coordinated efforts to promote the prevention and control of the epidemic and economic and social development.
But at the same time, it should be recognized that there are still shortcomings in emergency research and development, medical protective materials and departmental cooperation, "he said.
To this end, committee member jiao hong suggested taking the epidemic prevention and control as an opportunity to further consolidate the legal basis for the emergency management of drugs and medical devices.
We will solidify effective practices and good experience in the prevention and control of the epidemic in the form of laws and regulations, and build a legal system for the emergency management of drugs and medical devices that is complete, interconnected and efficient.
To study and formulate the emergency use system of medical devices in China, and to detail the corresponding procedures.
We will further improve the emergency approval system for drugs and medical devices with early intervention, joint research and review, on-going review and scientific review as the core, so as to ensure the safety and effectiveness of drugs and medical devices and ensure the scientific coordination of the urgent needs of epidemic prevention and control.
In order to effectively ensure the development, production and supply of medicines and medical devices needed to cope with major public health emergencies, jiao suggested that a national medical device emergency platform should be set up with scientific authority, unified command, efficient operation and strong guarantee.
The platform should strengthen collaborative, by the science and technology, health, drug administration and other relevant departments, emergency medicine medical instrument research and development, testing, review of examination and approval, production and supply, treatment, monitoring and evaluation is an organic whole, into a high level of technical team and strong r&d team and its cooperative enterprise, focus the superiority strength to strengthen interaction, coordination, with the fastest speed, to ensure the safe and effective YaoXie put into clinical use.
We will improve the platform's decision-making mechanism for major issues, information sharing and release mechanism, and expert consultation mechanism in the course of responding to major public health emergencies, so as to ensure the platform's materialized operation under emergency conditions.
Jiao also suggested that the emergency support system for medical devices should be improved.
Scientific planning based on the response to major public health emergencies emergency materials reserve system, increase drug medical equipment related to the support of basic science research, strengthening the frontier technology reserves, strengthen the national examination and review of technologies such as unit capacity building for examination and approval, support for enterprise innovation, grasp the key core technology;
We will support technological innovation on the front lines of epidemic prevention and control and emergency treatment, and enhance our ability to tackle key scientific problems in wartime.
In terms of talent construction, strengthen the pharmaceutical industry innovation leader in talent training, improve the scientific research institutes, leading enterprises, medical institutions, government agencies, and effective coordination mechanism, accelerate the specialization of professional inspectors, review of member of team construction, the introduction of more high level professional and technical personnel, clear career development channels of professional and technical personnel.
At the same time, should take an active part in international affairs YaoXie, deeply involved in the world health organization and other international organization affairs, deepen the drug regulatory agency of cooperation and exchange with other countries, and actively respond to a major public health emergencies of international scientific research cooperation, share key virus detection and vaccine development in information, improve coping capacity.
Source: China medical news
The copyright of this article belongs to the original, does not represent the position of this site.
We reprint this article for the purpose of disseminating more information.